Compare CGEM & AXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CGEM | AXG |
|---|---|---|
| Founded | 2016 | 2021 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 671.7M | 790.2M |
| IPO Year | 2021 | 2023 |
| Metric | CGEM | AXG |
|---|---|---|
| Price | $11.84 | $3.99 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $28.13 | N/A |
| AVG Volume (30 Days) | 707.4K | ★ 764.9K |
| Earning Date | 02-26-2026 | 01-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $7,656,000.00 |
| Revenue This Year | N/A | $28.53 |
| Revenue Next Year | N/A | $54.60 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 216.49 |
| 52 Week Low | $5.68 | $1.16 |
| 52 Week High | $13.33 | $5.09 |
| Indicator | CGEM | AXG |
|---|---|---|
| Relative Strength Index (RSI) | 57.77 | 47.48 |
| Support Level | $11.53 | $4.00 |
| Resistance Level | $12.99 | $4.19 |
| Average True Range (ATR) | 0.76 | 0.28 |
| MACD | 0.12 | -0.05 |
| Stochastic Oscillator | 61.36 | 15.29 |
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.